<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="46217">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02504567</url>
  </required_header>
  <id_info>
    <org_study_id>Laser</org_study_id>
    <nct_id>NCT02504567</nct_id>
  </id_info>
  <brief_title>Laser Ablation Study for trEatment of atRial Fibrillation (LASER)</brief_title>
  <acronym>LASER</acronym>
  <official_title>Laser Ablation Study for trEatment of atRial Fibrillation (LASER)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Clinic of Barcelona</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>CardioFocus</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Clinic of Barcelona</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This protocol aims at assessing the efficacy of performing catheter ablation for atrial
      fibrillation (AF) with laser catheters versus performing it with radiofrequency (RF)
      catheters. In order to study laser catheter ablation efficacy, MRI analysis of the lesions 3
      months after the procedure will be performed in both groups. MRI analysis will detect
      ablation gaps in the lesions encircling pulmonary veins. The primary endpoint will compare
      the number of gaps in the laser catheter and the RF group. The secondary endpoint of the
      study is recurrence of AF after 12 months. The target population of the study is patients
      with paroxysmal or persistent AF undergoing AF ablation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Actual">November 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Investigator</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Presence of large gaps in the delayed enhancement MRI (DE-MRI)</measure>
    <time_frame>3 months</time_frame>
    <description>The presence of MRI ablation gaps around the pulmonary veins evaluated with MRI images of the patient acquired three months after the ablation procedure. A large gap is described as a GAP that is larger or equal than 20% of the vein perimeter.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>To determine the number of patients that present atrial fibrillation after the ablation procedure</measure>
    <time_frame>1 year</time_frame>
    <description>The number of patients that present a recurrence in their atrial fibrillation after the ablation procedure during the first year.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">64</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Laser ablation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Ablation with laser catheter</description>
  </arm_group>
  <arm_group>
    <arm_group_label>RF ablation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Ablation with RF catheter</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Laser ablation</intervention_name>
    <description>Pulmonary vein isolation using the laser ablation catheter</description>
    <arm_group_label>Laser ablation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>RF ablation</intervention_name>
    <description>Pulmonary vein isolation using the RF ablation catheter</description>
    <arm_group_label>RF ablation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with clinical recurrent AF, refractary or intolerant to at least 1
             antiarrhythmic drub who are scheduled to undergo ablation of pulmonary veins (PV)

          -  Signed consent form.

        Exclusion Criteria:

          -  Being under 18 years old

          -  Any contraindication for ablation procedure

          -  Impossibility to acquire DE-MRI because of contraindication (e.g. severely impaired
             renal function) or patient unwillingness
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Lluís Mont, MD PhD</last_name>
    <phone>+3493227551</phone>
    <email>lmont@clinic.ub.es</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Antonio Berruezo, MD PhD</last_name>
    <phone>+34932275551</phone>
    <email>berruezo@clinic.ub.es</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Clínic de Barcelona</name>
      <address>
        <city>Barcelona</city>
        <state>Catalunya</state>
        <zip>08028</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lluís Mont, MD PhD</last_name>
      <phone>+34932275551</phone>
      <email>lmont@clinic.ub.es</email>
    </contact>
    <contact_backup>
      <last_name>Antonio Berruezo, MD PhD</last_name>
      <phone>+34932275551</phone>
      <email>berruezo@clinic.ub.es</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <lastchanged_date>February 22, 2017</lastchanged_date>
  <firstreceived_date>July 15, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Clinic of Barcelona</investigator_affiliation>
    <investigator_full_name>Josep Lluis Mont Girbau</investigator_full_name>
    <investigator_title>MD Phd</investigator_title>
  </responsible_party>
  <keyword>Catheter Ablation</keyword>
  <keyword>Radiofrequency</keyword>
  <keyword>Laser</keyword>
  <keyword>Atrial Fibrillation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
